Bone infection is a common and serious complication in the orthopedics field, which often leads to excessive bone destruction and non-union. Osteoclast is the only type of cells which have the function of bone resorption. Its over activation is closely related to excessive bone loss.
environment and can widely bind to host defense proteins to alter the host immune response (Kobayashi & DeLeo, 2013) . SPA could also inhibit osteoblast activity, prohibit osteogenesis through a variety of ways, which is an important cause of bone non-union (Heilmann, 2011; Jauregui, Mansell, Jepson, & Jenkinson, 2013) . However, there are few reports about the effects of SPA on osteoclastogenesis and its molecular mechanism.
Osteoclasts are derived from hematopoietic stem cell lineage, which is the only polykaryocytes with bone resorption function in the human skeletal system (Berglund, 2011; Rachner, Khosla, & Hofbauer, 2011) . It is well known that macrophage colony stimulating factor (M-CSF) and
Receptor activator of nuclear factor (NF)-κB ligand (RANKL) are two of the most important cytokines in the process of osteoclast differentiation (Teitelbaum & Ross, 2003) . During RANKL induced osteoclastogenesis, Mitogen-activated protein (MAP) kinases play an important role in regulating the proliferation, differentiation, and bone resorption function of osteoclast. MAP kinases, including ERK, P38, and JNK, which can lead to the activation of transcription factor NFATc1, and eventually promotes osteoclast formation and leads to excessive bone loss (Intini, Katsuragi, Kirkwood, & Yang, 2014) . In our research, MAP kinases could be obviously activated by SPA in osteoclast differentiation.
In the present study, we found that SPA could promote osteoclast formation. At the same time, we reported that SPA may regulate osteoclast formation by activating MAP kinase. 
| Clinical specimens and histological analysis
Three patients diagnosed with traumatic osteomyelitis infected by S.
aureus were selected in this study. We also selected the other three patients suffered fracture as control group for the study. Considering the difference of bone mass in different ages, the age of patients ranged from 18 to 30 years old. All samples with the size of 1 × 1 cm were obtained from the fracture site during surgery. This research was approved by Ethics Committee of Daping hospital and performed according to relevant laws.
For histological analysis, samples were fixed in 4% paraformaldehyde for 24 hr. Samples were then decalcified by 10% EDTA solution for 1 month, and the solution was changed every twice days. Samples were prepared into 8 µm thickness bone slices after paraffin embedded, and standard TRAP and HE stain was performed, respectively.
| Cell viability assay in vitro
RAW264.7 cells were cultured in DMEM containing 1% penicillinstreptomycin solution and 10% FBS at 37°C in 5% CO 2 condition.
RAW264.7 cells were seeded into 96-well plates at a density of 3 × 103 per well. After adherence, cells were incubated with different dosages of SPA in the presence of 50 ng/ml RANKL and 50 ng/ml M-CSF for 24 and 72 hr, respectively. Cell Counting Kit-8 was used to assess cell viability according to the manufacturers' directions. The absorbency of cells was measured using a 96-well plate reader at 450 nm.
| Cell apoptosis assay
RAW264.7 cells were cultured in the presence of 50 ng/ml RANKL and 50 ng/ml M-CSF with different dosages of SPA (0, 0.1, 1, 10, 100 µg/ ml) for 24 and 72 hr, respectively. Apoptosis rate of RAW264. 2.5 | Tartrate-resistant acid phosphatase (TRAP) assay RAW264.7 cells were cultured with 50 ng/ml RANKL and 50 ng/ml M-CSF with SPA treatment (0, 0. 1, 1, 10, 100 µg/ml). TRAP stain was conducted as previously described (Dou et al., 2016) . Briefly, after cultivation for 72 hr, cells were washed with PBS and fixed with 4% paraformaldehyde for 5 min, and then stained with TRAP staining solution for 1 hr at 37°C protected from light according to the protocol. Multinucleated TRAP-positive cells containing three or more nuclei were considered as osteoclast. 
| Real-time qPCR
Total RNA was extracted from cells by using Trizol reagent (Life Technologies). The cDNA was synthesized using reverse Table 1 .
| Western blots
Cells were lysed in PMSF buffer to extract total protein. The samples were transferred to the PVDF membrane using the wet transfer method. After blocking in TBST solution containing 5% skim milk for 2 hr, the bands were incubated with primary antibodies against ERK, JNK, P38 p-ERK, p-JNK, p-P38, c-FOS, NFATc1, and β-actin overnight at 4°C. The bands were washed and incubated with secondary antibody for 1 hr at room temperature. β-actin was performed as an internal control.
| Statistical analysis
All experiments were performed at least three times. All data are expressed as mean ± SD. One-way ANOVA was used to evaluated the significance of difference between two groups of data, with *p < 0.05, **p < 0.01 being regarded as significant.
3 | RESULTS
| S. aureus activated osteoclast and promoted bone loss in clinical specimens
The sections were stained with TRAP and HE stain solution and were then observed under the light microscope. Compared with infection group, the thickness of bone trabecula was thinner in non-infection group ( Figure 1A) . Meanwhile, the results of TRAP staining showed that OC surface/bone surface ratio was significantly increased 3.2 | SPA toxicity evaluation and effects on cell apoptosis RAW264.7 cells were incubated with different dosages of SPA with or without RANKL and M-CSF for 24 and 72 hr, respectively. CCK-8 assay was used to evaluate the effects of SPA on cell proliferation.
The results revealed that SPA concentration at 1,000 µg/ml significantly inhibited cell proliferation (Figure 2A ). In addition, the effect of SPA on cell apoptosis during RANKL induced osteoclastogenesis was assessed by Annexin-V/PI Staining. The results showed that SPA had no effect on both early and late apoptosis rate (Supplementary Figure S1 ).
| SPA promotes RANKL-induced osteoclast differentiation in vitro
According to the results of CCK8 assay, SPA dosages at 0.1, 1, 10, and 100 µg/ml were selected for further study. RAW264.7 cells were cultured with different dosages of SPA in the presence of RANKL and M-CSF for 72 hr. TRAP stain was performed in order to observe osteoclast differentiation ( Figure 2B ). The number of osteoclasts (nuclei ≥ 3) were counted. The results of statistical analysis showed that the number of osteoclasts in the experimental group increased significantly compared with the control group ( Figure 2C) . Interestingly, the number of osteoclasts were not significantly increased when the concentration of SPA was 100 µg/ml compared with SPA concentration at 10 µg/ml, but the images showed that the morphology of osteoclasts was larger than other groups. Consistently, qPCR results also revealed that 
| SPA promoted RANKL-induced osteoclast fusion in vitro
To investigate the effects of SPA on osteoclast fusion, we observed osteoclast cytoskeleton by FAK staining, and the number of osteoclasts and average nuclei were counted ( Figure 4A ). Quantification analysis showed that the number of osteoclasts and average nuclei of osteoclasts was significantly increased by SPA treatments ( Figure 4B ). As the results of TRAP stain, the number of osteoclasts was not increased when SPA concentration was 100 µg/ml compared with 10 µg/ml, but average nuclei number was increased significantly. Consequently, SPA could increase RANKL-induced osteoclast formation.
| SPA enhances RANKL-induced osteoclast bone resorption activity in vitro
Bone resorption assay was carried on to evaluate the effects of SPA on osteoclast bone resorption activity. RAW264.7 cells were cultured in 48-well plates covered with bovine bone slices RANKL, M-CSF, and different dosages of SPA for 5 days. Bone resorption areas were analyzed to assess bone resorption activity of osteoclast ( Figure 5A ). Statistical results showed that bone resorption areas were significantly increased by SPA treatment ( Figure 5B ). The results showed that SPA could enhance osteoclast bone resorption activity.
| SPA promoted RANKL-induced osteoclastogenesis by upregulating NFATc1 and c-FOS through MAPK pathways
To explain the mechanism of SPA on osteoclast differentiation, we detected the expression of ERK, JNK, P38, and its phosphorylation levels p-ERK, p-JNK, and p-P38 in MAPK pathways by Western blots.
The results showed that the expression of p-ERK, p-JNK, and p-P38
was increased compared with its non-phosphorylation levels by SPA treatment ( Figure 6A ). At the same time, the expression of NFATc1 and c-FOS which were downstream of MAPK signaling were tested (Qiao et al., 2016) , and the results showed that the expression was significantly increased (Figure 6B-D) .The expression of NFATc1 and c-FOS were not increased when phosphorylation inhibitors of ERK, JNK, and P38 MAPK were administered ( Figure 6E ). We also detected the expression of NFATc1 and c-FOS by qPCR (Figure 3) , and the | 2403 results showed that both of them were significantly increased which were consistent with the results of Western blots. In addition, IRF9, as a c-FOS inhibitor gene, was detected by qPCR. The results showed that the expression was significantly decreased.
| DISCUSSION
Most infectious bone diseases such as osteomyelitis, Orthopedic
Device Related Infections (ODRI), and Periprothetic Joint Infections (PJI)are mainly caused by S. aureus (Cassat et al., 2013; Kahl, Becker, & Loffler, 2016; Vaudaux et al., 2012) . In addition to the typical inflammation symptoms, the most characteristic of these diseases is accompanied by excessive bone destruction and bone non-union (Olson & Horswill, 2013) . Previous reports demonstrated that the femoral bone mass was lost about 10-20% in rat models which were infected by S. aureus (Mendoza Bertelli et al., 2016) . In case of trauma or surgery, S. aureus could break through the host barrier for local colonization, is extremely easy to produce bacterial biofilm. Once the biofilm formed, it is able to protect S. aureus from being eliminated by the host immune defense and antibiotics, resulting in consecutively infection (Conlon et al., 2013) . The products of S. aureus such as SPA could continue to stimulate osteoblast and osteoclast, leading to changing of the normal process in bone remodeling (Claro et al., 2011; Jin et al., 2013; Widaa, Claro, Foster, O'Brien, & Kerrigan, 2012) . In our study, we found that SPA promotes osteoclast differentiation and fusion, and also enhances osteoclastic bone resorption activity. (Cavagis et al., 2014; Wei, Kitaura, Zhou, Ross, & Teitelbaum, 2005) .
In addition, we found that MAP kinases including ERK, JNK, and promote NFATc1 activation resulting in osteoclast formation (Takayanagi, 2003) .
As we know, bone formation is another important aspect of bone remodeling, which is mainly controlled by osteoblast. Numerous studies have demonstrated that S. aureus and its virulence factors can decrease osteoblast activity and induce apoptosis through directly invading osteoblast or binding to surface receptors (Chen et al., 2014; Josse et al., 2016) . Recently, it has been reported that SPA can accelerate apoptosis of osteoblast, suppress osteoblast proliferation, and inhibit the process of bone formation and mineralization (Kahl et al., 2016) . Meanwhile, SPA may stimulate immune cells to produce a variety of inflammatory cytokines such as IFN-γ, IL-1, IL-6, and TNF-α which could synergize with RANKL to promote osteoclastogenesis (Huang, Drissi, O'Keefe, & Schwarz, 2003) . Consequently, SPA may play an important role in bone non-union and excessive bone destruction caused by bone infection. Nevertheless, S. aureus can produce a variety of virulence factors and its effect on bone remolding is very complex, which suggests that we need further research to understand the mechanism of bone infection.
In conclusion, our study demonstrated that SPA treatment promotes osteoclast differentiation and fusion, and increases bone 
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